Skip to Content

IXICO PLC PHYOF

Morningstar Rating
$0.15 −0.05 (25.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PHYOF is trading at a 382% premium.
Price
$0.15
Fair Value
$2.92
Uncertainty
Extreme
1-Star Price
$6.96
5-Star Price
$7.14
Economic Moat
Dbjkm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PHYOF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.20
Day Range
$0.150.15
52-Week Range
$0.000.77
Bid/Ask
$0.00 / $0.77
Market Cap
$7.25 Mil
Volume/Avg
1,000 / 1,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.89
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
89

Valuation

Metric
PHYOF
Price/Earnings (Normalized)
Price/Book Value
0.52
Price/Sales
0.89
Price/Cash Flow
Price/Earnings
PHYOF

Financial Strength

Metric
PHYOF
Quick Ratio
3.64
Current Ratio
3.64
Interest Coverage
−84.48
Quick Ratio
PHYOF

Profitability

Metric
PHYOF
Return on Assets (Normalized)
−14.29%
Return on Equity (Normalized)
−16.42%
Return on Invested Capital (Normalized)
−16.57%
Return on Assets
PHYOF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
MrjhrkdkYrkt$631.1 Bil
Vertex Pharmaceuticals Inc
VRTX
TfkxgfvlGplgrp$120.6 Bil
Regeneron Pharmaceuticals Inc
REGN
SthvlhpqQhptljc$114.5 Bil
Moderna Inc
MRNA
BgsxxfrrxNnv$51.1 Bil
argenx SE ADR
ARGX
WkjgwvvtMmm$22.6 Bil
BioNTech SE ADR
BNTX
YlcrcrycQkyg$20.8 Bil
Alnylam Pharmaceuticals Inc
ALNY
GgckxgpqwPcvgyn$19.5 Bil
Biomarin Pharmaceutical Inc
BMRN
RzwtcllfQsyxjqv$16.0 Bil
United Therapeutics Corp
UTHR
PkpspnnxWmns$13.6 Bil
Incyte Corp
INCY
VwbbqwdFfpsdf$12.1 Bil

Sponsor Center